This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Tuberculosis, Pulmonary or Antibiotic Prophylaxis
and you are
between 18 and 45
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine if the isoniazid is effective in the prevention of tuberculosis in a prison population, exposed to the high endemicity of the disease.

Provided treatments

  • Drug: Isoniazid 900 milligrams
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028129. The sponsor of the trial is Federal University of Mato Grosso do Sul and it is looking for 467 volunteers for the current phase.
Official trial title:
Primary Prophylaxis for Prevention of TB in Prison's Populations